DZHK-Retreat

Kontakt:

Dr. Ute Eggers

Referentin Wissenschaftlicher Austausch | Gruppe Strategie, Präklinische Forschung & Nachwuchsförderung

E-mail: retreat(at)dzhk.de


Retreat 2020 is going digital

Aufgrund der Corona-Krise wird das DZHK-Retreat 2020 nicht als Präsenz-, sondern als Online-Veranstaltung stattfinden.

Es wird unser erstes digitales Retreat sein. Das Programm findet statt am Donnerstag, 17. September, von 15.30 Uhr bis 18.30 Uhr und am Freitag, 18. September, von 13.00 Uhr bis 17.15 Uhr.


Retreat Programme

Day 1 Thursday, 17 September 2020 – 03:30 pm to 06:30 pm
03:30 pm – 04:05 pm Opening: Welcome & DZHK State of Affairs, Thomas Eschenhagen, Hamburg/Kiel/Lübeck
04:15 pm – 04:20 pm Break
04:20 pm – 06:30 pm 1 st Session: New concepts in inflammatory cardiovascular disease, Chairs: Michael Joner, Friederike Schreiter
04:25 pm – 04:35 pm Innervation regulates arterial inflammation, Sarajo Mohanta, Munich
04:40 pm – 04:55 pm Clonal hematopoiesis regulates vascular inflammation, Andreas Zeiher, Rhine-Main
05:00 pm – 05:15 pm GITR a novel checkpoint in atherosclerosis, Esther Lutgens, Munich/Amsterdam
05:20 pm – 05:35 pm scRNA-seq analysis of murine atherosclerosis, Alma Zernecke-Madsen (Würzburg)
05:40 pm – 05:55 pm Platelets and cardiovascular inflammation, Steffen Massberg, Munich
06:00 pm – 06:15 pm An unexpected role for basophils in healing after myocardial infarction, Florian Leuschner, Heidelberg/Mannheim
06:20 pm – 06:30 pm Brief wrap-up
Day 2 Friday, 18 September 2020 – 01:00 pm to 05:15 pm
01:00 pm – 01:20 pm Keynote, Chair: Lars Mägdefessel, Immuno-imaging and immunotherapy in atherosclerosis, Zahi Fayad (Icahn School of Medicine at Mount Sinai, New York)
01:30 pm – 02:35 pm 2nd Session: Flash Talks Paper of the Month, Chairs: Shirin Doroudgar, Eileen Moritz
01:35 pm – 01:38 pm Midkine drives cardiac inflammation by promoting neutrophil trafficking and NETosis in myocarditis, Ulrich Grabmaier, Munich
01:40 pm – 01:43 pm ApoE attenuates unresolvable inflammation by complex formation with activated C1q, Changjun Yin, Munich
01:45 pm – 01:48 pm High-throughput single-cell rheology in complex samples by dynamic real-time deformability cytometry, Bob Fregin, Greifswald
01:50 pm – 01:53 pm Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions, Andreas Daiber, Rhein-Main
01:55 pm – 01:58 pm Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death, Carlos Silvestre-Roig, Munich
02:00 pm – 02:03 pm The translational landscape of the human heart, Jana Felicitas Schulz, Berlin
02:05 pm – 02:08 pm Magnetic resonance perfusion or fractional flow reserve in coronary disease, Eike Nagel, Rhine-Main
02:10 pm – 02:13 pm Application of highsSensitivity troponin in suspected myocardial infarction, Johannes T. Neumann, Hamburg/Kiel/Lübeck
02:15 pm – 02:18 pm TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation, Jörg Heineke, Heidelberg/Mannheim
02:20 pm – 02:23 pm Cardiac alpha-Actin (ACTC1) gene mutation causes atrial-septal defects associated with late-onset dilated cardiomyopathy, Derk Frank, Hamburg/Kiel/Lübeck
02:25 pm – 02:28 pm Ticagrelor or prasugrel in patients with acute coronary syndromes, Stefanie Schüpke, Munich
02:30 pm – 02:33 pm Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium, Fabian Brunner (Hamburg)
02:35 pm – 02:50 pm Break
02:50 pm – 05:00 pm 3rd Session: Targeting the inflammasome in clinical practice, Chairs: Tommaso Gori, Lucia Natarelli
02:55 pm – 03:15 pm Targeting the NLRP3 inflammasome in inflammatory diseases, Eike Latz (Bonn)
03:25 pm – 03:35 pm Do we need sex specific therapeutic adaptation? Elke Dworatzek, Berlin
03:40 pm – 03:50 pm Phenotyping myocarditis to guide therapy, Valentina Puntmann, Rhine-Main
03:55 pm – 04:05 pm Pleiotropic effects and inflammation: Targeting the comorbidities, Stephan von Haehling, Göttingen
04:10 pm – 04:20 pm Rhythm control therapy in patients with atrial fibrillation: a translational update, Paulus Kirchhof, Hamburg/Kiel/Lübeck
04:25 pm – 04:35 pm Addressing inflammation by lipid reduction – novel molecular therapies, Ulf Landmesser, Berlin
04:40 pm – 04:45 pm Wrap-up and introduction of the new DZHK Workshop series
04:45 pm – 05:15 pm Some words of gratitude to Thomas Eschenhagen und Joachim Krebser

Allgemein

Das DZHK-Retreat ist die wissenschaftliche Jahrestagung des DZHK, welche einmal jährlich an wechselnden Standorten stattfindet. Für das Retreat kommen rund 250 DZHK-Wissenschaftlerinnen und Wissenschaftler aus den Standorten und Partnereinrichtungen zusammen, um neueste Entwicklungen der Herz-Kreislaufmedizin zu diskutieren. Neben themenspezifischen Sessions, geben renommierte Keynote Speaker aus aller Welt wichtige Impulse für die Forschung. Flankierend finden Arbeitsgruppen- und Gremiensitzungen sowie eine Posterausstellung statt. Im Vorfeld der Veranstaltung trifft sich das Young-DZHK zum Young-DZHK Retreat.

Rückblick

DZHK Retreat 2019

DZHK Retreat 2018

DZHK Retreat 2017